Dare Bioscience, Inc. — Director's Dealing 2015

Dec 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-11-30

Reporting Person: WALT DAVID R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-30	Common Stock	P	5374	$3.249	Acquired	17491	Direct

Footnotes

F1: Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $3.19 to $3.29 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.